Robertson Danielle M, Ho Su-Inn, Hansen Baranda S, Petroll W Matthew, Cavanagh H Dwight
Department of Ophthalmology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9057, USA.
Exp Eye Res. 2007 Oct;85(4):492-501. doi: 10.1016/j.exer.2007.06.015. Epub 2007 Jun 29.
Insulin-like Growth Factor Binding Protein-3 (IGFBP3) is a high-affinity binding protein shown to regulate cell growth, differentiation, and apoptosis in a variety of cellular systems. The primary aim of this study was to characterize IGFBP3 expression in the human corneal epithelium and in a corneal epithelial cell line and to establish a potential role for IGFBP3-mediated apoptotic signaling in corneal epithelial cells. Using a telomerase-immortalized human corneal epithelial (hTCEpi) cell line cultured in serum-free media and fresh human eye bank donor tissue, expression and localization of IGFBP3 were established in situ and in vitro by indirect immunofluorescence and western blotting. Real-time PCR was used to measure IGFBP3 mRNA levels following Trichostatin A (TSA) treatment and as a function of confluence. IGFBP3 protein levels were assessed in resting human tears and in conditioned media by western blotting as was the ability of recombinant human IGFBP3 protein to associate with the cell surface. Apoptotic signaling was assessed in vitro using TSA and recombinant human (rh)IGFBP3. Apoptosis was measured by Viability/Cytotoxicity, Annexin V, and TUNEL assays. IGFBP3 was localized to the plasma membrane of human corneal epithelial cells in situ and was upregulated in surface cells in the central cornea. IGFBP3 was secreted in conditioned media of growing cells, with a robust upregulation following confluence (P=0.014) and differentiation. IGFBP3 was undetectable in human tears. Addition of TSA to the culture media resulted in an upregulation of IGFBP3 mRNA (P<0.001) and protein. In addition, TSA treatment led to a significant increase in Annexin V positive cells at 18 and 24h (P<0.001) and TUNEL positive cells at 24 and 48 h (P<0.001). The addition of rhIGFBP3 to the cell culture media appeared to induce occasional membrane blebbing, but cells failed to become positive with Annexin V or TUNEL. Taken together, these results demonstrate that cell membrane-associated IGFBP3 is produced by corneal epithelial cells and associates with the plasma membrane of superficial cells in situ and in cultured cells, but not present in human tears. The differential localization and effect(s) on apoptosis suggest that the effects of IGFBP3 are likely tissue compartment and receptor specific and may be regulated by glycosylation.
胰岛素样生长因子结合蛋白-3(IGFBP3)是一种高亲和力结合蛋白,已证实在多种细胞系统中可调节细胞生长、分化和凋亡。本研究的主要目的是表征IGFBP3在人角膜上皮和角膜上皮细胞系中的表达,并确定IGFBP3介导的凋亡信号在角膜上皮细胞中的潜在作用。使用在无血清培养基中培养的端粒酶永生化人角膜上皮(hTCEpi)细胞系和新鲜的人眼库供体组织,通过间接免疫荧光和蛋白质印迹在原位和体外确定IGFBP3的表达和定位。实时PCR用于测量曲古抑菌素A(TSA)处理后以及作为汇合度函数的IGFBP3 mRNA水平。通过蛋白质印迹评估静息人泪液和条件培养基中的IGFBP3蛋白水平,以及重组人IGFBP3蛋白与细胞表面结合的能力。使用TSA和重组人(rh)IGFBP3在体外评估凋亡信号。通过活力/细胞毒性、膜联蛋白V和TUNEL测定法测量凋亡。IGFBP3在原位定位于人角膜上皮细胞的质膜,并在中央角膜的表面细胞中上调。IGFBP3在生长细胞的条件培养基中分泌,汇合(P = 0.014)和分化后有强烈上调。在人泪液中未检测到IGFBP3。向培养基中添加TSA导致IGFBP3 mRNA(P < 0.001)和蛋白质上调。此外,TSA处理导致18和24小时时膜联蛋白V阳性细胞显著增加(P < 0.001),24和48小时时TUNEL阳性细胞显著增加(P < 0.001)。向细胞培养基中添加rhIGFBP3似乎偶尔诱导细胞膜起泡,但细胞未变为膜联蛋白V或TUNEL阳性。综上所述,这些结果表明细胞膜相关的IGFBP3由角膜上皮细胞产生,并在原位和培养细胞中与表面细胞质膜结合,但不存在于人泪液中。对凋亡的不同定位和影响表明IGFBP3的作用可能是组织隔室和受体特异性的,并且可能受糖基化调节。